Your browser doesn't support javascript.
loading
The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergency.
Nisii, C; Vincenti, D; Fusco, F M; Schmidt-Chanasit, J; Carbonnelle, C; Raoul, H; Eickmann, M; Hewson, R; Brave, A; Nuncio, S; Sanchez-Seco, M P; Palyi, B; Kis, Z; Zange, S; Nitsche, A; Kurth, A; Strasser, M; Capobianchi, M R; Ozin, A; Guglielmetti, P; Menel-Lemos, C; Jacob, D; Grunow, R; Ippolito, G; Di Caro, A.
Afiliação
  • Nisii C; 'Lazzaro Spallanzani' National Institute for Infectious Diseases-IRCCS, Rome, Italy.
  • Vincenti D; 'Lazzaro Spallanzani' National Institute for Infectious Diseases-IRCCS, Rome, Italy.
  • Fusco FM; 'Lazzaro Spallanzani' National Institute for Infectious Diseases-IRCCS, Rome, Italy.
  • Schmidt-Chanasit J; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Carbonnelle C; Laboratoire INSERM Jean Mérieux, Lyon, France.
  • Raoul H; Laboratoire INSERM Jean Mérieux, Lyon, France.
  • Eickmann M; Institute of Virology, University of Marburg, Marburg, Germany.
  • Hewson R; Public Health England, Porton Down, Salisbury, UK.
  • Brave A; SMI, Solna, Sweden.
  • Nuncio S; Instituto Nacional de Saude, Lisbon, Portugal.
  • Sanchez-Seco MP; Centro Nacional de Microbiologia, ISCIII, Madrid, Spain.
  • Palyi B; National Center for Epidemiology, Budapest, Hungary.
  • Kis Z; National Center for Epidemiology, Budapest, Hungary.
  • Zange S; Bundeswehr Institute of Microbiology, Munich, Germany.
  • Nitsche A; Robert Koch Institut, Berlin, Germany.
  • Kurth A; Robert Koch Institut, Berlin, Germany.
  • Strasser M; Federal Office for Civil Protection, Spiez Laboratory, Switzerland.
  • Capobianchi MR; 'Lazzaro Spallanzani' National Institute for Infectious Diseases-IRCCS, Rome, Italy.
  • Ozin A; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Guglielmetti P; European Commission, DG SANTE, Health Threats Unit, Luxembourg.
  • Menel-Lemos C; European Commission, Consumers, Health, Agriculture and Food Executive Agency (CHAFEA), Luxembourg.
  • Jacob D; Robert Koch Institut, Berlin, Germany.
  • Grunow R; Robert Koch Institut, Berlin, Germany.
  • Ippolito G; 'Lazzaro Spallanzani' National Institute for Infectious Diseases-IRCCS, Rome, Italy.
  • Di Caro A; 'Lazzaro Spallanzani' National Institute for Infectious Diseases-IRCCS, Rome, Italy. Electronic address: antonino.dicaro@inmi.it.
Clin Microbiol Infect ; 23(2): 58-60, 2017 Feb.
Article em En | MEDLINE | ID: mdl-27404371
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Contenção de Riscos Biológicos / Laboratórios Tipo de estudo: Diagnostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Contenção de Riscos Biológicos / Laboratórios Tipo de estudo: Diagnostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article